AIM ImmunoTech (AIM) Misses Q2 EPS by 360c
AIM ImmunoTech (NYSE: AIM) reported Q2 EPS of ($3.68), $3.60 worse than the analyst estimate of ($0.08).
For earnings history and earnings-related data on AIM ImmunoTech (AIM) click here.
AIM ImmunoTech (NYSE: AIM) reported Q2 EPS of ($3.68), $3.60 worse than the analyst estimate of ($0.08).
For earnings history and earnings-related data on AIM ImmunoTech (AIM) click here.